Amalgamated Bank Amgen Inc Transaction History

Amalgamated Bank

$11.7 Billion
Q2 2024

A detailed history of Amalgamated Bank transactions in Amgen Inc stock. As of the latest transaction made, Amalgamated Bank holds 113,663 shares of AMGN stock, worth $35.9 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

113,663

Previous 114,204 0.47%

Holding current value

$35.9 Million

Previous $32.5 Million 9.37%

% of portfolio

0.3%

Previous 0.28%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$262.75 - $319.31 $142,147 - $172,746	-541 Reduced 0.47%	113,663 $35.5 Million
Q1 2024 Apr 23, 2024	SELL	$268.87 - $324.56 $4.62 Million - $5.57 Million	-17,172 Reduced 13.07%	114,204 $32.5 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $1.7 Million - $1.92 Million	-6,666 Reduced 4.83%	131,376 $37.8 Million
Q3 2023 Nov 08, 2023	SELL	$218.65 - $271.46 $681,750 - $846,412	-3,118 Reduced 2.21%	138,042 $37.1 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $3.39 Million - $4 Million	-15,806 Reduced 10.07%	141,160 $31.3 Million
Q1 2023 May 02, 2023	BUY	$225.79 - $275.2 $2.78 Million - $3.39 Million	12,314 Added 8.51%	156,966 $37.9 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $703,809 - $894,273	-3,073 Reduced 2.08%	144,652 $38 Million
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $1.49 Million - $1.68 Million	6,627 Added 4.7%	147,725 $33.3 Million
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $3.67 Million - $4.08 Million	-15,909 Reduced 10.13%	141,098 $34.3 Million
Q1 2022 Jun 30, 2022	BUY	$219.27 - $242.57 $690,700 - $764,095	3,150 Added 2.05%	157,007 $38 Million
Q4 2021 Feb 15, 2022	BUY	$198.88 - $227.6 $4.45 Million - $5.09 Million	22,364 Added 17.01%	153,857 $34.6 Million
Q3 2021 Oct 29, 2021	SELL	$212.27 - $248.7 $1.65 Million - $1.93 Million	-7,773 Reduced 5.58%	131,493 $28 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $24.2 Million - $26.8 Million	103,478 Added 289.14%	139,266 $33.9 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $388,786 - $453,067	-1,752 Reduced 4.67%	35,788 $8.9 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $122,038 - $145,325	-564 Reduced 1.48%	37,540 $8.63 Million
Q3 2020 Oct 30, 2020	SELL	$234.65 - $260.95 $281,110 - $312,618	-1,198 Reduced 3.05%	38,104 $9.69 Million
Q2 2020 Aug 10, 2020	SELL	$197.81 - $242.74 $11.6 Million - $14.2 Million	-58,552 Reduced 59.84%	39,302 $9.27 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $858,714 - $1.14 Million	-4,712 Reduced 4.59%	97,854 $19.8 Million
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $579,928 - $745,408	3,065 Added 3.08%	102,566 $24.7 Million
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $3.13 Million - $3.75 Million	17,963 Added 22.03%	99,501 $19.3 Million
Q2 2019 Aug 14, 2019	SELL	$166.7 - $195.41 $2.14 Million - $2.5 Million	-12,817 Reduced 13.58%	81,538 $15 Million
Q1 2019 May 15, 2019	BUY	$180.87 - $203.88 $152,292 - $171,666	842 Added 0.9%	94,355 $17.9 Million
Q4 2018 Feb 15, 2019	SELL	$178.4 - $208.25 $658,474 - $768,650	-3,691 Reduced 3.8%	93,513 $18.2 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $963,878 - $1.09 Million	-5,202 Reduced 5.08%	97,204 $20.1 Million
Q2 2018 Jul 18, 2018	BUY	$166.05 - $186.51 $1.47 Million - $1.65 Million	8,861 Added 9.47%	102,406 $18.9 Million
Q1 2018 May 22, 2018	SELL	$169.43 - $198.0 $60,994 - $71,280	-360 Reduced 0.38%	93,545 $15.9 Million
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $1.4 Million - $1.56 Million	8,266 Added 9.65%	93,905 $16.3 Million
Q3 2017 Nov 09, 2017	BUY	$167.29 - $191.0 $14.3 Million - $16.4 Million	85,639	85,639 $16 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Amgen Inc Transaction History